PCI looks to Boston for growth; 3M signs on to help Mylan make generic Advair;

> Contract drugmaker PCI Synthesis is increasingly looking to its native Boston for partnership deals, tapping the area's fast-growing biotech ecosystem to flesh out its client base. Story

> 3M ($MMM) has signed on to help Mylan ($MYL) manufacture the delivery device key to its generic version of GlaxoSmithKline's ($GSK) blockbuster COPD treatment Advair. News

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.